BCM
CVO

Bayesian Capital Management’s Cenevo, Inc. CVO Stock Holding History

Bayesian Capital Management’s Portfolio CVO Stock Details CVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,850
Closed -$7K – 607
2016
Q1 		$7K Buy
+1,850
New +$7.57K 0.01% 342

Other funds holding CVO

ZC
Zelman Capital Beachwood, Ohio $81.9M AUM 22.32% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
WCM
Wallace Capital Management Dallas, Texas $871M AUM 13.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AWW
Alan W. Weber $336M AUM 75.94% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bayesian Capital Management's CVO Position: Q2 2016 in Review

Bayesian Capital Management sold out of Cenevo, Inc. (CVO) in Q2 2016, closing a stake of 1,850 shares — an estimated $7K sold.

Bayesian Capital Management first reported a position in CVO in Q1 2016 and held it in 1 quarter. The position peaked at $7K in Q1 2016. 53 funds tracked by Wall St. Rank hold CVO as of Q2 2016.

  • Bayesian Capital Management reported no remaining Cenevo, Inc. position as of Q2 2016 after selling out during the quarter.
  • Bayesian Capital Management sold 1,850 Cenevo, Inc. shares in Q2 2016, an estimated $7K.
  • Bayesian Capital Management first reported a position in Cenevo, Inc. in Q1 2016 and held it in 1 quarter.
  • Bayesian Capital Management's Cenevo, Inc. position peaked at $7K in Q1 2016.
  • 53 funds tracked by Wall St. Rank held Cenevo, Inc. as of Q2 2016.

Based on Bayesian Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.